BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33663422)

  • 1. Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.
    Zou Y; Zhang H; Li W; Guo Y; Sun F; Shi Y; Gong Y; Lu X; Wang W; Xia S
    BMC Cancer; 2021 Mar; 21(1):221. PubMed ID: 33663422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prediction model for lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma: Based on dual-energy CT.
    Zou Y; Sun S; Liu Q; Liu J; Shi Y; Sun F; Gong Y; Lu X; Zhang X; Xia S
    Eur J Radiol; 2021 Dec; 145():110060. PubMed ID: 34839216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma.
    Zhao W; Shen S; Ke T; Jiang J; Wang Y; Xie X; Hu X; Tang X; Han D; Chen J
    Eur Radiol; 2024 Jan; 34(1):16-25. PubMed ID: 37526667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
    Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
    Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
    Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
    Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
    Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms based on sonographic and clinicopathological characteristics to predict lateral lymph node metastasis in classic papillary thyroid carcinoma.
    Feng JW; Wu WX; Qi GF; Hong LZ; Hu J; Liu SY; Jiang Y; Ye J
    J Endocrinol Invest; 2022 Nov; 45(11):2043-2057. PubMed ID: 35809195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prediction model incorporating the BRAF
    Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
    Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.
    Yoon J; Choi Y; Jang J; Shin NY; Ahn KJ; Kim BS
    PLoS One; 2021; 16(12):e0261233. PubMed ID: 34898649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.
    Rui ZY; Liu Y; Zheng W; Wang X; Meng ZW; Tan J; Li N; Jia Q
    Clin Exp Med; 2021 May; 21(2):277-286. PubMed ID: 33386568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
    Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
    Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study.
    Gong J; Zhu B; Liu W; Shi C; Xia C; Zeng L; Lv Y
    Horm Metab Res; 2023 May; 55(5):315-322. PubMed ID: 36934720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
    Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
    Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
    Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
    Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Texture analysis of dual-phase contrast-enhanced CT in the diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer.
    Su GY; Xu XQ; Zhou Y; Zhang H; Si Y; Shen MP; Wu FY
    Acta Radiol; 2021 Jul; 62(7):890-896. PubMed ID: 32757639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.
    Feng JW; Qin AC; Ye J; Pan H; Jiang Y; Qu Z
    Endocr Pathol; 2020 Mar; 31(1):67-76. PubMed ID: 31828583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    Ye L; Hu L; Liu W; Luo Y; Li Z; Ding Z; Hu C; Wang L; Zhu Y; Liu L; Ma X; Kong Y; Huang L
    BMC Cancer; 2021 Nov; 21(1):1250. PubMed ID: 34800991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of arterial enhancement fraction derived from dual-energy computed tomography for preoperative diagnosis of cervical lymph node metastasis in papillary thyroid cancer: initial results.
    Zhou Y; Xu YK; Geng D; Wang JW; Chen XB; Si Y; Shen MP; Su GY; Xu XQ; Wu FY
    Eur Radiol; 2024 Feb; 34(2):1292-1301. PubMed ID: 37589903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
    Shao L; Wang Z; Dong W; Sun W; Zhang H
    Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.